381 related articles for article (PubMed ID: 21670497)
1. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.
Benezra M; Penate-Medina O; Zanzonico PB; Schaer D; Ow H; Burns A; DeStanchina E; Longo V; Herz E; Iyer S; Wolchok J; Larson SM; Wiesner U; Bradbury MS
J Clin Invest; 2011 Jul; 121(7):2768-80. PubMed ID: 21670497
[TBL] [Abstract][Full Text] [Related]
2. A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica Nanoparticles.
Urbanska AM; Khanin R; Alidori S; Wong S; Mello BP; Almeida BA; Chen F; Ma K; Turker MZ; Korontsvit T; Scheinberg DA; Zanzonico PB; Wiesner U; Bradbury MS; Quinn TP; McDevitt MR
Cancer Biother Radiopharm; 2020 Aug; 35(6):459-473. PubMed ID: 32013538
[TBL] [Abstract][Full Text] [Related]
3. Use of Ultrasmall Core-Shell Fluorescent Silica Nanoparticles for Image-Guided Sentinel Lymph Node Biopsy in Head and Neck Melanoma: A Nonrandomized Clinical Trial.
Zanoni DK; Stambuk HE; Madajewski B; Montero PH; Matsuura D; Busam KJ; Ma K; Turker MZ; Sequeira S; Gonen M; Zanzonico P; Wiesner U; Bradbury MS; Patel SG
JAMA Netw Open; 2021 Mar; 4(3):e211936. PubMed ID: 33734415
[TBL] [Abstract][Full Text] [Related]
4. Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.
Chakravarty R; Goel S; Hong H; Chen F; Valdovinos HF; Hernandez R; Barnhart TE; Cai W
Nanomedicine (Lond); 2015; 10(8):1233-46. PubMed ID: 25955122
[TBL] [Abstract][Full Text] [Related]
5. Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model.
Juthani R; Madajewski B; Yoo B; Zhang L; Chen PM; Chen F; Turker MZ; Ma K; Overholtzer M; Longo VA; Carlin S; Aragon-Sanabria V; Huse J; Gonen M; Zanzonico P; Rudin CM; Wiesner U; Bradbury MS; Brennan CW
Clin Cancer Res; 2020 Jan; 26(1):147-158. PubMed ID: 31515460
[TBL] [Abstract][Full Text] [Related]
6. Molecular phenotyping and image-guided surgical treatment of melanoma using spectrally distinct ultrasmall core-shell silica nanoparticles.
Chen F; Madajewski B; Ma K; Karassawa Zanoni D; Stambuk H; Turker MZ; Monette S; Zhang L; Yoo B; Chen P; Meester RJC; de Jonge S; Montero P; Phillips E; Quinn TP; Gönen M; Sequeira S; de Stanchina E; Zanzonico P; Wiesner U; Patel SG; Bradbury MS
Sci Adv; 2019 Dec; 5(12):eaax5208. PubMed ID: 31840066
[TBL] [Abstract][Full Text] [Related]
7. Ligands for mapping alphavbeta3-integrin expression in vivo.
Schottelius M; Laufer B; Kessler H; Wester HJ
Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
[TBL] [Abstract][Full Text] [Related]
9. Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer.
Chen F; Ma K; Madajewski B; Zhuang L; Zhang L; Rickert K; Marelli M; Yoo B; Turker MZ; Overholtzer M; Quinn TP; Gonen M; Zanzonico P; Tuesca A; Bowen MA; Norton L; Subramony JA; Wiesner U; Bradbury MS
Nat Commun; 2018 Oct; 9(1):4141. PubMed ID: 30297810
[TBL] [Abstract][Full Text] [Related]
10. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
11. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery.
Lee JE; Lee N; Kim H; Kim J; Choi SH; Kim JH; Kim T; Song IC; Park SP; Moon WK; Hyeon T
J Am Chem Soc; 2010 Jan; 132(2):552-7. PubMed ID: 20017538
[TBL] [Abstract][Full Text] [Related]
12. PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.
Lee HY; Li Z; Chen K; Hsu AR; Xu C; Xie J; Sun S; Chen X
J Nucl Med; 2008 Aug; 49(8):1371-9. PubMed ID: 18632815
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.
Rosenholm JM; Mamaeva V; Sahlgren C; Lindén M
Nanomedicine (Lond); 2012 Jan; 7(1):111-20. PubMed ID: 22191780
[TBL] [Abstract][Full Text] [Related]
14. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
Hartono SB; Gu W; Kleitz F; Liu J; He L; Middelberg AP; Yu C; Lu GQ; Qiao SZ
ACS Nano; 2012 Mar; 6(3):2104-17. PubMed ID: 22385282
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan degrading silica nanoparticles for skin cancer therapy.
Scodeller P; Catalano PN; Salguero N; Duran H; Wolosiuk A; Soler-Illia GJ
Nanoscale; 2013 Oct; 5(20):9690-8. PubMed ID: 23969526
[TBL] [Abstract][Full Text] [Related]
16. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
[TBL] [Abstract][Full Text] [Related]
17. Chitosan mediated 5-Fluorouracil functionalized silica nanoparticle from rice husk for anticancer activity.
Dhinasekaran D; Raj R; Rajendran AR; Purushothaman B; Subramanian B; Prakasarao A; Singaravelu G
Int J Biol Macromol; 2020 Aug; 156():969-980. PubMed ID: 32320807
[TBL] [Abstract][Full Text] [Related]
18. Negative-charge-functionalized mesoporous silica nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Xie M; Xu Y; Shen H; Shen S; Ge Y; Xie J
Int J Pharm; 2014 Oct; 474(1-2):223-31. PubMed ID: 25149125
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
20. Melanocortin-1 Receptor-Targeting Ultrasmall Silica Nanoparticles for Dual-Modality Human Melanoma Imaging.
Chen F; Zhang X; Ma K; Madajewski B; Benezra M; Zhang L; Phillips E; Turker MZ; Gallazzi F; Penate-Medina O; Overholtzer M; Pauliah M; Gonen M; Zanzonico P; Wiesner U; Bradbury MS; Quinn TP
ACS Appl Mater Interfaces; 2018 Feb; 10(5):4379-4393. PubMed ID: 29058865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]